Related Experiment Videos
Screening Young syndrome patients for CFTR mutations
K J Friedman1, H Teichtahl, D M De Kretser
1Department of Hospital Laboratories, University of North Carolina, Chapel Hill 27514, USA.
American Journal of Respiratory and Critical Care Medicine
|October 1, 1995
Summary
Young syndrome, a condition causing obstructive azoospermia and sinobronchial disease, is unlikely linked to cystic fibrosis transmembrane regulator (CFTR) gene mutations. Genetic screening found no significant CFTR mutation prevalence in affected individuals.
Area of Science:
- Genetics
- Reproductive Medicine
- Pulmonology
Background:
- Young syndrome presents with obstructive azoospermia and chronic sinobronchial infections.
- Some cases of congenital bilateral absence of the vas deferens (CBAVD) are linked to CFTR gene mutations.
- Similarities between Young syndrome, cystic fibrosis (CF), and CBAVD suggest a potential genetic connection.
Purpose of the Study:
- To investigate the potential role of cystic fibrosis transmembrane regulator (CFTR) gene mutations in Young syndrome.
- To screen patients with Young syndrome for known CFTR gene mutations.
Main Methods:
- Evaluated 13 patients diagnosed with Young syndrome.
- Screened for over 30 different mutations within the CFTR gene.
- Assessed sweat chloride concentration and pulmonary function (FEV1).
Main Results:
- Normal sweat chloride concentrations were observed in all patients.
- One patient (1 in 26 chromosomes) carried the delta F508 CFTR mutation.
- The incidence of CFTR mutations did not significantly differ from the general population carrier frequency.
Conclusions:
- It is unlikely that typical Young syndrome is caused by mutations in both alleles of the CFTR gene.
- The study suggests that CFTR mutations are not a primary cause of Young syndrome.
- Further research may be needed to explore other potential genetic or environmental factors.